Balazs Halmos, Professor of Medicine at Montefiore Health System, shared on X:
“I was asked to sum up recently how the outlook has changed in the management of patients with advanced NSCLC in the last 25 years.
Starting from the precipice of survival curves with doublet chemotherapy in ECOG1594 – to the broadening plateaus we see with targeted and immunotherapy.
How it started. How it is going.
Very much hope we can keep the momentum to get more and more patients on that solid plateau with a gorgeous outlook of long-term survival!”
More from Balazs Halmos on OncoDaily.